Abstract
Introduction
The purpose of this study was to establish the efficacy and safety of the Ex-PRESS (Optonol Ltd., Neve Ilan, Israel) mini glaucoma shunt in open-angle glaucoma.
Methods
This was a prospective, randomized trial. Eyes from enrolled patients were randomly assigned to either Ex-PRESS implantation under a scleral flap, or trabeculectomy. The main outcome measures were: mean intraocular pressure (IOP), postoperative medication use, visual acuity, and incidence of complications. Complete success was defined as an IOP of >4 mmHg and ≤18 mmHg without the use of antiglaucoma medications. A more stringent target of IOP >4 mmHg and ≤15 mmHg was also noted.
Results
There were 78 patients (80 eyes) with primary open-angle, pseudoexfoliative, or pigmentary glaucoma enrolled in the study. A total of 84.6% of patients receiving Ex-PRESS and 60.0% of patients receiving trabeculectomy (P=0.0230) achieved complete success. The respective proportions of patients achieving an IOP >4 mmHg and ≤15 mmHg were 76.9% and 50.0% (P=0.0193). At 1-year follow-up, complete success rates were 81.8% for Ex-PRESS and 47.5% for trabeculectomy (P=0.0020), and 71.7% and 37.5% (P=0.0070), respectively, for the more stringent target. There was a similar level of postoperative interventions and complications for each group.
Conclusions
In open-angle glaucoma, the Ex-PRESS mini glaucoma shunt implanted under a superficial scleral flap produces significantly higher success rates, and a similar complication rate, compared with trabeculectomy. The Ex-PRESS is a safe and effective device for treating open-angle glaucoma.
Similar content being viewed by others
References
Hendrick AM, Kahook MY. Ex-PRESS mini glaucoma shunt: surgical technique and review of clinical experience. Expert Rev Med Device. 2008;5:673–678.
Quigley HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097–1106.
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267.
Gressel M, Parrish RI, Heuer D. Delayed nonexpulsive suprachoroidal hemorrhage. Arch Ophthalmol. 1984;102:1757–1760.
Belyea D, Dan J, Stamper R, Lieberman M, Spencer W. Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C. Am J Ophthalmol. 1997;124:40–45.
Higginbotham E, Stevens R, Musch D, et al. Blebrelated endophthalmitis after trabeculecotomy with mitomycin. Ophthalmology. 1996;103:650–656.
Mermoud A, Schnyder C, Sickenberg M, Chiou A, Hediguer S, Faggioni R. Comparison of deep sclerectomy with collagen implant and trabeculectomy in open-angle glaucoma. J Cataract Refract Surg. 1999;25:323–331.
Parrish RI, Schiffman J, Feuer W, Heuer D. Prognosis and risk factors for early postoperative wound leaks after trabeculectomy with and without 5-fluorouracil. Am J Ophthalmol. 2001;132:633–640.
Rothman R, Liebmann J, Ritch R. Low-dose 5-fluorouracil trabeculectomy as initial surgery in uncomplicated glaucoma: long-term follow-up. Ophthalmology. 2000;107:1184–1190.
Ruderman JM, Harbin TS Jr, Campbell D. Postoperative suprachoroidal hemorrhage following filtration procedures. Arch Ophthalmol. 1986;104:201–205.
Stewart W, Shields M. Management of anterior chamber depth after trabeculectomy. Am J Ophthalmol. 1988;106:41–44.
Ticho U, Ophir A. Late complications after glaucoma filtering surgery with adjunctive 5-fluorouracil. Am J Ophthalmol. 1993;115:506–510.
Cairns D. Trabeculectomy: a preliminary report of a new method. Am J Ophthalmol. 1968;66:673–679.
Skuta G, Parrish RI. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32:149–170.
El-Sayyad F, Helal M, El-Kholify H, Khalil M, El-Maghraby A. Non-penetrating deep sclerectomy versus trabeculectomy in bilateral primary open angle glaucoma. Ophthalmology. 2000;107:1671–1674.
Netland P. Ophthalmic Technology Assessment Committee Glaucoma Panel. American Academy of Ophthalmology. Nonpenetrating glaucoma surgery. Ophthalmology. 2001;108:416–421.
Traverso C, De Feo F, Messas-Kaplan A, et al. Long term effect on IOP of a stainless steel glaucoma drainage implant (Ex-PRESS) in combined surgery with phacoemulsification. Br J Ophthalmol. 2005;89:425–429.
Dahan E, Carmichael T. Implantation of a miniature glaucoma device under a scleral flap. J Glaucoma. 2005;14:98–102.
Moses RA. The Goldmann applanation tonometer. Am J Ophthalmol. 1958;46:865–869.
Camparini M, Cassinari P, Ferrigno L, Macaluso C. ETDRS-fast: implementing psychophysical adaptive methods to standardized visual acuity measurement with ETDRS charts. Invest Ophthalmol Vis Sci. 2001;42:1226–1231
Maris P, Ishida K, Netland P. Comparison of trabeculectomy with Ex-PRESS miniature glaucoma device implanted under scleral flap. J Glaucoma. 2007;16:14–19.
Fontana H, Nouri-Mahdavi K, Caprioli J. Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure. Am J Ophthalmol. 2006;141:652–659.
Goldenfeld M, Krupin T, Ruderman J, et al. 5-fluorouracil in initial trabeculectomy: a prospective, randomized, multicenter study. Ophthalmology. 1994;101:1024–1029.
Mastropasqua L, Carpineto P, Ciancaglini M, Zuppardi E, Lobefalo L, Gallenga P. Delayed postoperative use of 5-fluorouracil as an adjunct in medically uncontrolled open angle glaucoma. Eye. 1998;12:701–706.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de Jong, L.A.M.S. The Ex-PRESS glaucoma shunt versus trabeculectomy in open-angle glaucoma: a prospective randomized study. Adv Therapy 26, 336–345 (2009). https://doi.org/10.1007/s12325-009-0017-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-009-0017-6